Patents by Inventor Minesh Mehta

Minesh Mehta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11197836
    Abstract: Vasoconstrictors are administered topically to provide protection against the adverse effects, e.g., alopecia, mucositis or dermatitis, induced by chemotherapy or radiotherapy. Appropriate dosages and formulations of topical vasoconstrictors are provided. Methods for the use of such compositions are also provided.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: December 14, 2021
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: William E. Fahl, Arnold E. Ruoho, Minesh Mehta
  • Publication number: 20160136113
    Abstract: Vasoconstrictors are administered topically to provide protection against the adverse effects, e.g., alopecia, mucositis or dermatitis, induced by chemotherapy or radiotherapy. Appropriate dosages and formulations of topical vasoconstrictors are provided. Methods for the use of such compositions are also provided.
    Type: Application
    Filed: November 6, 2015
    Publication date: May 19, 2016
    Applicant: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: William E. Fahl, Arnold E. Ruoho, Minesh Mehta
  • Publication number: 20120316246
    Abstract: Vasoconstrictors are administered topically to provide protection against the adverse effects, e.g., alopecia, mucositis or dermatitis, induced by chemotherapy or radiotherapy. Appropriate dosages and formulations of topical vasoconstrictors are provided. Methods for the use of such compositions are also provided.
    Type: Application
    Filed: July 17, 2012
    Publication date: December 13, 2012
    Inventors: William E. Fahl, Arnold E. Ruoho, Minesh Mehta
  • Patent number: 8247457
    Abstract: Vasoconstrictors are administered topically to provide protection against the adverse effects, e.g., alopecia, mucositis or dermatitis, induced by chemotherapy or radiotherapy. Appropriate dosages and formulations of topical vasoconstrictors are provided. Methods for the use of such compositions are also provided.
    Type: Grant
    Filed: May 12, 2011
    Date of Patent: August 21, 2012
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: William E. Fahl, Arnold E. Ruoho, Minesh Mehta
  • Patent number: 8114914
    Abstract: Vasoconstrictors are administered topically to provide protection against the adverse effects, e.g., alopecia, mucositis or dermatitis, induced by chemotherapy or radiotherapy. Appropriate dosages and formulations of topical vasoconstrictors are provided. Methods for the use of such compositions are also provided.
    Type: Grant
    Filed: June 19, 2006
    Date of Patent: February 14, 2012
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: William E. Fahl, Arnold E. Ruoho, Minesh Mehta
  • Publication number: 20110218223
    Abstract: Vasoconstrictors are administered topically to provide protection against the adverse effects, e.g., alopecia, mucositis or dermatitis, induced by chemotherapy or radiotherapy. Appropriate dosages and formulations of topical vasoconstrictors are provided. Methods for the use of such compositions are also provided.
    Type: Application
    Filed: May 12, 2011
    Publication date: September 8, 2011
    Inventors: William E. Fahl, Arnold E. Ruoho, Minesh Mehta
  • Publication number: 20070225268
    Abstract: Described is a method of inhibiting the growth of neoplastic cells. The method includes the steps of contacting neoplastic cells with a gadolinium-containing compound for a time sufficient to allow the gadolinium-containing compound to be internalized within the neoplastic cells. The neoplastic cells are then exposed to a photon flux sufficient to induce emission of Auger electrons from the gadolinium-containing compound. The emitted Auger electrons induce non-reparable double-stranded DNA cleavage within the neoplastic cells, which thus inhibits the growth of the neoplastic cells. The method is particularly suitable for treating glioblastomas in humans.
    Type: Application
    Filed: December 29, 2006
    Publication date: September 27, 2007
    Inventors: Pupa Gilbert, Minesh Mehta, Francois Esteve
  • Publication number: 20070077219
    Abstract: Vasoconstrictors are administered topically to provide protection against the adverse effects, e.g., alopecia, mucositis or dermatitis, induced by chemotherapy or radiotherapy. Appropriate dosages and formulations of topical vasoconstrictors are provided. Methods for the use of such compositions are also provided.
    Type: Application
    Filed: June 19, 2006
    Publication date: April 5, 2007
    Applicant: Wisconsin Alumni Research Foundation
    Inventors: William Fahl, Arnold Ruoho, Minesh Mehta